White-label dashboards
Your logo, colours and navigation; dashboards embedded in your screens through EMB-S, for closed groups of users or public publishing.
- Industries
- Healthcare & life sciences
- CTMS Software Vendors
CTMS software vendors
Analytics your sponsors expect —
Analytics your sponsors expect —
under your brand, inside your CTMS.
TURBOARD embeds white-labelled dashboards, scheduled reports and the JAS AI assistant in your clinical trial software, so you offer a full analytics layer without building one.
The challenge
Sponsors expect analytics — building it is not your core business.
Sponsors and CROs choosing a clinical trial management system now expect interactive dashboards, flexible reporting and natural-language questions as standard. Developing that in-house means a permanent team of BI engineers, designers and data specialists, a long road to release, and a reporting layer that has to keep up with every new client request.
TURBOARD gives you that layer as an embedded, white-labelled product. Dashboards appear inside your screens under your brand, each client sees only its own studies, and JAS answers your users’ questions from the governed data. The model is proven: PharmaCircle, the US pharma intelligence provider, has embedded our visualisation engine since 2004 — through it, 79% of large pharma companies use it.
500K+business users work with TURBOARD
Since 2004enterprise BI engineering, founded in Chicago
Cloud or on-premisefully on-premise deployment, AI included
PatentedBI technology, including a granted US patent
What you can do
What embedding TURBOARD adds to your CTMS
Client-level data separation
Row-level permissions keep every sponsor, CRO and site within its own studies, from one shared model.
Ready study analytics
Subject recruitment, eligibility, dropouts, visit and lab analysis, rating-scale outcomes and adverse events by severity, arm and dose.
JAS inside your product
Your users ask questions in plain language and get charts with their sources; JAS Explain writes an interpretation of any dashboard.
Scheduled client reports
PDF, Excel, PowerPoint and Word reports delivered by e-mail to each client’s recipients, on queues proven at 100K recipients.
Deployment that follows your customers
Run in the cloud or fully on-premise including the AI, so the analytics go wherever your software is installed.
Challenges & solutions
Building analytics yourself — versus embedding TURBOARD
?A permanent in-house team
BI developers, designers and data engineers are needed before the first dashboard ships, and after.
✓A mature engine from day one
Connectors, ETL, visualisation, permissions, distribution and AI come with the platform, developed since 2004.
?Long time to market
An analytics module competes with your core roadmap for the same engineering capacity.
✓Embed and configure
Your team integrates the embedded views and focuses on the clinical workflows your clients buy your system for.
?Generic BI that does not fit
General tools lack clinical trial context and are hard to tailor to your data model and screens.
✓Domain experience
Our pharma and clinical data work since 2004, with PharmaCircle as proof, shapes how the analytics fit your product.
?Analytics as a cost centre
A reporting layer you build and maintain adds cost without a line on the invoice.
✓A module you can sell
White-labelled analytics and AI become a feature your clients pay for, under your brand.
JAS · Just Ask Simply
Give your users an AI assistant that knows their trials
Embedded in your CTMS, JAS answers from the governed data and only within each user’s permissions. She finds existing reports first, writes the query when needed, and builds or edits a chart on command. With personas, a clinical operations lead and a sponsor executive each get an explanation suited to their role.
Explore JAS capabilities →JJASQuestions you can ask
- Which sites in study 118 have the highest screen-failure rate?
- Show enrolment against plan for all active studies by country.
- Summarise serious adverse events this month by study arm.
- Which monitoring visits are overdue by more than 30 days?